Skip to main content
Verified Statutory Healthcare Resource — Indian Pharmacopoeia (IP) / CDSCO / PMBJP Jan Aushadhi Standards
Fever & Pain 5 min read • Last Updated: September 2026

Crocin vs Dolo 650: Dosage, Active Salts & Generic Savings Guide

Clinical comparison between Crocin 500mg and Dolo 650mg: active salts, fever dosage limits, liver safety, and 84% Jan Aushadhi generic cost savings.

Statutory Medical Disclaimer & Emergency Safety Notice The pharmacological and therapeutic data presented in this educational guide is synthesized exclusively for public health literacy, academic reference, and educational purposes in conformity with the Indian Pharmacopoeia (IP 2022) and guidelines established by the Central Drugs Standard Control Organisation (CDSCO). This content does not constitute medical diagnosis, formal physician opinion, or individualized therapeutic instruction. Under the Drugs and Cosmetics Act, 1940 and the National Medical Commission (Professional Conduct) Regulations, Schedule H, H1, and X pharmaceutical formulations must be prescribed and monitored by a registered medical practitioner (RMP). Patients must not initiate, alter, or terminate any therapeutic drug regimen without formal clinical evaluation by their treating physician or a licensed healthcare professional. For acute medical emergencies, dial 112 / 108 (India) immediately.
🩺 Quick Clinical Answer

Both Crocin and Dolo 650 contain Paracetamol (Acetaminophen) IP. Crocin contains 500mg (suitable for mild fever/headache), while Dolo 650 contains 650mg (prescribed for high fever and severe body pain). Jan Aushadhi generic Paracetamol 650mg is available for ₹5.50 per strip with identical bioequivalence.

1. Active Salt & Dosage Differences

Crocin 500 contains 500mg of Paracetamol IP per tablet, recommended for mild fever and tension headaches. Dolo 650 contains 650mg of Paracetamol IP, routinely prescribed in India for viral febrile illnesses (dengue, chikungunya, influenza) and acute muscular body aches.

2. Safe Daily Limits & Liver Protection

The absolute maximum daily ceiling for Paracetamol in healthy adults is 4,000 mg within 24 hours. For Dolo 650, this equates to a maximum of 6 tablets daily, spaced at least 4 to 6 hours apart. Exceeding this threshold risks hepatic toxicity due to accumulation of the toxic metabolite NAPQI.

3. Jan Aushadhi Generic Substitute

Branded Dolo 650 retails at approximately ₹34.00 for a strip of 15 tablets. At Pradhan Mantri Bhartiya Janaushadhi Kendras, bioequivalent Paracetamol 650mg tablets cost just ₹5.50 for a strip of 10 tablets—providing an immediate 84% cost savings.

PMBJP Jan Aushadhi Price Transparency

Top 8 Essential Indian Medicines: Branded MRP vs. Jan Aushadhi Generic Comparison

Compare average Indian retail MRP of top branded formulations against government-certified PMBJP Jan Aushadhi bioequivalent generic prices and active salts. Verified against official PMBJP formularies, NPPA price caps, and CDSCO regulatory registries.

Brand Name Leading Manufacturer Active Salt Formulation (IP) Branded MRP Jan Aushadhi Price Savings %
Augmentin 625 Duo GlaxoSmithKline Pharmaceuticals Amoxicillin Trihydrate 500mg + Potassium Clavulanate 125mg IP ₹220.00 ₹58.00 74%
Dolo 650 Micro Labs Ltd Paracetamol (Acetaminophen) 650mg IP ₹34.00 ₹5.50 84%
Pantocid 40 Sun Pharmaceutical Industries Pantoprazole Sodium 40mg IP (Gastro-resistant) ₹155.00 ₹8.00 95%
Azithral 500 Alembic Pharmaceuticals Azithromycin Dihydrate 500mg IP ₹132.00 ₹24.00 82%
Glycomet 500 USV Private Limited Metformin Hydrochloride 500mg IP ₹24.00 ₹4.50 81%
Shelcal 500 Torrent Pharmaceuticals Elemental Calcium 500mg + Cholecalciferol (Vit D3) 250 IU IP ₹134.00 ₹16.00 88%
Telma 40 Glenmark Pharmaceuticals Telmisartan 40mg IP ₹92.00 ₹7.50 92%
Montair-LC Cipla Ltd Montelukast Sodium 10mg + Levocetirizine Dihydrochloride 5mg IP ₹210.00 ₹18.00 91%
Combined 8-Drug Essential Therapy Basket Total: ₹1,001.00 ₹141.00 85.9% Net Savings
Additional high-volume Indian medicines bioequivalent generic savings: Atorva 10 (Atorvastatin 10mg: Branded ₹110.00 vs Jan Aushadhi ₹12.00, 89% savings), Allegra 120 (Fexofenadine 120mg: Branded ₹215.00 vs Jan Aushadhi ₹32.00, 85% savings). Official Portal: PMBJP National Formulary (janaushadhi.gov.in) →

Frequently Asked Questions (Clinical & Regulatory)

Q1: Can I take Dolo 650 on an empty stomach?

Paracetamol is gentler on the gastric lining than NSAIDs like ibuprofen, but taking it after a light snack or with water is recommended to prevent nausea.

Q2: How many hours gap should be kept between two Dolo 650 tablets?

Maintain an interval of at least 4 to 6 hours between doses. Never take two tablets at the same time.

Q3: What is the maximum daily safe limit for Paracetamol in adults?

Under Indian Pharmacopoeia and CDSCO guidance, the absolute ceiling for adult paracetamol dosing from all sources is 4,000 mg per 24 hours (or 3,200 mg in prolonged administration). Exceeding this limit rapidly depletes hepatic glutathione and leads to toxic accumulation of N-acetyl-p-benzoquinone imine (NAPQI), resulting in acute hepatocellular necrosis.

Q4: Can Jan Aushadhi generic paracetamol be substituted for branded tablets like Dolo 650 or Calpol?

Yes. Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) paracetamol tablets contain identical Paracetamol IP at tested NABL bioequivalence standards (80–125% AUC confidence interval), delivering identical antipyretic and analgesic efficacy at ₹5.50 per strip compared to ₹34.00 for branded formulations.

Q5: Why should NSAIDs like Ibuprofen or Diclofenac be avoided during suspected dengue fever?

In undiagnosed acute febrile illnesses, particularly dengue fever, NSAIDs impair platelet aggregation and cause gastric mucosal erosions, sharply elevating the risk of severe internal gastrointestinal hemorrhage and dengue hemorrhagic syndrome. Paracetamol remains the only safe first-line antipyretic.

Clinically Reviewed by MediMatch AI Clinical Pharmacology Review Board
IP • CDSCO • PMBJP Standards Statutory Citations ▾

This clinical guide is authored and reviewed in accordance with the regulatory standards of the Indian Pharmacopoeia (IP), Central Drugs Standard Control Organization (CDSCO) drug schedules, and Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) bioequivalence guidelines. All therapeutic recommendations and drug interaction warnings are cross-referenced with official statutory publications.

Digital Personal Data Protection (DPDP) Act, 2023 Statutory Health Privacy Disclosure

Under India's Digital Personal Data Protection (DPDP) Act, 2023, MediMatch AI functions as a data fiduciary committed to zero retention of private health identifiers. Browsing educational guides, reviewing active salt monographs, and executing search queries occur without tracking or commercial profiling. All client interactions with prescription readers or lab decoders execute ephemerally in volatile memory with zero server-side storage of protected health information (PHI). For inquiries regarding data fiduciary obligations, contact our Data Protection Officer at privacy@medimatchai.in.